CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks...

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

How Does Biotechnology Help Agriculture Sector Reap Benefits

How Does Biotechnology Help...

Biotechnology in Agriculture: Key Applications and Significance to Know

Biotechnology in Agriculture: Key...

DNA Sequencing Everything You Need to Know

DNA Sequencing Everything You Need to...

The Applications of Data Analytics in Biotechnology

The Applications of Data Analytics in...

BioCardia to Support Development of Potential Cell Therapy Products

BioCardia to Support Development of...

ProPhase Labs Expects Business Expansion with Key Promotions and Addition to Management Team

ProPhase Labs Expects Business...

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks...

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

How Does Biotechnology Help Agriculture Sector Reap Benefits

How Does Biotechnology Help...

Biotechnology in Agriculture: Key Applications and Significance to Know

Biotechnology in Agriculture: Key...

DNA Sequencing Everything You Need to Know

DNA Sequencing Everything You Need to...

The Applications of Data Analytics in Biotechnology

The Applications of Data Analytics in...

BioCardia to Support Development of Potential Cell Therapy Products

BioCardia to Support Development of...

ProPhase Labs Expects Business Expansion with Key Promotions and Addition to Management Team

ProPhase Labs Expects Business...

CorMedix Makes Leadership Changes to Enhance Drug Development

Life Sciences Review Life Sciences Review | Tuesday, October 26, 2021
Tweet

The new leadership changes will take forward the firm’s investigational drug product work.


FREMONT, CA: Despite advancements and initiatives to limit infection, catheter biofilm forms within 24 hours and can lead to life-threatening infections, costing the United States’ healthcare system billions of dollars each year. With an estimated 250,000 catheter-related bloodstream infections (CRBSIs) happening each year in the United States, it is no wonder that over 180 in-depth interviews with nephrologists, oncologists, and total parenteral nutrition (TPN) healthcare practitioners have revealed a huge unmet demand for CRBSI treatment. As a result, CorMedix, a biopharmaceutical business, is working on Defencath. This investigational drug product is being developed to prevent CRBSIs in patients with end-stage renal disease who are receiving hemodialysis through a central venous catheter.


“I am honored to take on the role of interim CEO during this important time for the company,” said Matt David, M.D., CorMedix’s EVP and Chief Financial Officer (CFO), who has been named interim CEO by the Board. CorMedix specializes in developing and commercializing therapeutics to prevent and treat infectious and inflammatory diseases. The firm has recently made changes to its executive leadership team. Khoso Baluch is stepped down as Chief Executive Officer (CEO) and resigned from the Company’s Board of Directors, effective October 4, 2021. John Armstrong, CorMedix’s EVP of Technical Operations, has left the company. Further, David’s job as CFO will be retained.


See Also : Drug Discovery And Development Companies


“On behalf of the entire Board, I thank Khoso and Jack for their dedicated service and contributions to CorMedix. Khoso has been instrumental in refocusing the company and guiding it strategically while building a highly experienced executive team,” said Myron Kaplan, Chairman of the Board of Directors. “Matt’s energy and leadership, with the support of CorMedix’s Board of Directors and experienced management team, enable him to continue the important work underway to progress DefenCath, while the CEO search is ongoing.”


The Board is beginning a search process with a leading executive search firm to recognize a permanent CEO. Baluch will serve the organization in an advisory capacity to promote a smooth transition. Phoebe Mounts, Ph.D., Esq., EVP, General Counsel, and Head of Regulatory, Compliance, and Legal, will have direct control over CorMedix’s Technical Operations group, which includes a specialized group of consultants tasked with addressing deficiencies discovered at CorMedix’s third-party manufacturing facility.


“With a strong executive team spanning regulatory, medical affairs, clinical operations and commercial, and a highly supportive Board which includes proven healthcare industry leaders, I believe we are well positioned to continue our efforts to bring DefenCath to the hemodialysis patient community,” commented David.


Weekly Brief

loading
Top 10 Leading BioTech Solution Companies - 2021
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue

Read Also

Everything You Need to Know About Medical Lab Equipment and their Applications

Everything You Need to Know About Medical Lab Equipment and their Applications

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks To Buy In 2022

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial
How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

The several benefits Of Agricultural Genome Editing

The several benefits Of Agricultural Genome Editing

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/cormedix-makes-leadership-changes-to-enhance-drug-development-nwid-611.html